Seeking Alpha

Pfizer (PFE) CEO Jeffrey Kindler says the firm's $7B/yr. R&D operation was failing when he...

Pfizer (PFE) CEO Jeffrey Kindler says the firm's $7B/yr. R&D operation was failing when he took control two years ago today. "We've tried to dismantle this monolithic structure of R&D and create smaller therapeutic areas."
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs